Table 3
Patient and caregiver follow-up measures
| Measure | Baseline (time point 0) mean score (SD) n=25 | Mean standardised effect size (d) from baseline | ||
| Time point 1 1–2 days post-IPOS (mean (  , SD)) n=24 | Time point 2 1–2 weeks post-IPOS (mean, SD) n=23 | Time point 3 4–6 weeks post-IPOS (mean, SD) n=23 | ||
| ESAS-r | 24.72 (16.73) | 0.05 | −0.31 | −0.11 |
( 23.9, SD 15.8) | ( 29.9, SD 19.6) | ( 26.5, SD 15.0) | ||
| KCCQ overall clinical summary score | 61.4 (25.4) | 0.18 | −0.23 | −0.02 |
( 62.6, SD 25.4) | ( 56.7, SD 17.2) | ( 59.8, SD 15.2) | ||
| KCCQ overall summary score | 56.6 (16.7) | −0.06 | −0.09 | −0.02 |
( 56.3, SD 14.7) | ( 54.4, SD 15.3) | ( 55.6, SD 16.7) | ||
| KCCQ self-efficacy score | 82.1 (18.0) | 0.29 | 0.44 | 0.44 |
( 88.0, SD 11.6) | ( 89.7, SD 9.7) | ( 89.7, SD13.4) | ||
| PHQ-8 | 3.20 (4.21) | 0.01 | 0.10 | 0.10 |
 3.0, SD 3.6) | ( 2.8, SD 4.4) | ( 2.8, SD 3.9) | ||
| Quality of life (VAS) | 5.15 (1.25) | 0.22 | 0.16 | 0.34 |
( 5.5, SD 1.4) | ( 5.4, SD 1.4) | ( 5.6, SD 1.0) | ||
| ZBI-12 | 21.90 (6.92) | – | – | −0.56 |
( 25.8, SD 3.2) | ||||
ESAS, Edmonton symptom assessment system; IPOS, Integrated Palliative care Outcome Scale; KCCQ, Kansas City Cardiomyopathy Questionnaire; PHQ-8: Patient-Health Questionnaire; VAS: Visual Analogue Scale; ZBI-12: Zarit Caregiver Burden Interview-12.